[1. Ettinger AB, Argoff CE. Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain. Neurotherapeutics. 2007;4:75-83.10.1016/j.nurt.2006.10.003]Search in Google Scholar
[2. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure. 2010;19:650-655.10.1016/j.seizure.2010.10.027]Open DOISearch in Google Scholar
[3. Kerr BM, Thummel KE, Wurden CJ, et al. Human liver carbamazepine metabolism. Biochem Pharmacol. 1994;47:1969-1979.10.1016/0006-2952(94)90071-X]Open DOISearch in Google Scholar
[4. Johannessen SI, Landmark CJ. Antiepileptic drug interactions - principles and clinical implications. Curr Neuropharmacol. 2010;8:254-267.10.2174/157015910792246254300121821358975]Search in Google Scholar
[5. Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49:1239-1276.10.1111/j.1528-1167.2008.01561.x18397299]Search in Google Scholar
[6. Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit. 2003;25:347-363.10.1097/00007691-200306000-0001612766564]Open DOISearch in Google Scholar
[7. Neels HM, Sierens AC, Naelaerts K, Scharpé SL, Hatfield GM, Lambert WE. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Vol. 42, Clinical Chemistry and Laboratory Medicine; 2004. p. 1228-1255.10.1515/CCLM.2004.24515576287]Search in Google Scholar
[8. Kim K-B, Seo K-A, Kim S-E, Bae SK, Kim D-H, Shin J-G. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal. 2011;56:771-777.10.1016/j.jpba.2011.07.01921840666]Search in Google Scholar
[9. Zhu Y, Chiang H, Wulster-Radcliffe M, et al. Liquid chromatography/tandem mass spectrometry for the determination of carbamazepine and its main metabolite in rat plasma utilizing an automated blood sampling system. J Pharm Biomed Anal. 2005;38:119-125.10.1016/j.jpba.2004.11.05815907629]Search in Google Scholar
[10. Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2005;828:80-90.10.1016/j.jchromb.2005.09.01916203183]Search in Google Scholar
[11. Subramanian M, Birnbaum AK, Remmel RP. High-Speed Simultaneous Determination of Nine Antiepileptic Drugs Using Liquid Chromatography-Mass Spectrometry. Ther Drug Monit. 2008;30:347-356.10.1097/FTD.0b013e3181678ecb18520607]Open DOISearch in Google Scholar
[12. Theodore WH, Narang PK, Holmes MD, Reeves P, Nice FJ. Carbamazepine and its epoxide: Relation of plasma levels to toxicity and seizure control. Ann Neurol. 1989;25:194-196.10.1002/ana.4102502152919868]Open DOISearch in Google Scholar
[13. Burianová I, Bořecká K. Routine therapeutic monitoring of the active metabolite of carbamazepine: Is it really necessary? Clin Biochem. 2015;48:866-869.]Search in Google Scholar
[14. Krasniqi S, Zeitlinger M, Bauer S. Comparison between the immunoassay and high performance liquid chromatography for therapeutic monitoring of carbamazepine and phenytoine. Biochem Medica. 2010;341-349.10.11613/BM.2010.044]Open DOISearch in Google Scholar
[15. Ferreira A, Rodrigues M, Oliveira P, et al. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine. J Chromatogr B Anal Technol Biomed Life Sci. 2014;971:20-29.10.1016/j.jchromb.2014.09.01025261836]Search in Google Scholar
[16. Shokry E, Villanelli F, Malvagia S, et al. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry. J Pharm Biomed Anal. 2015;109:164-170.10.1016/j.jpba.2015.02.04525770414]Search in Google Scholar
[17. Đorđević S, Kilibarda V, Stojanović T. Determination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection Odre đ ivanje karbamazepina u uzorcima seruma i salive primenom te č ne hromatografije visokih performansi sa ultravioletnom de. Vojn Pregl. 2009;66:347-352.10.2298/VSP0905347D19489468]Search in Google Scholar
[18. Krasowski MD, McMillin GA. Advances in anti-epileptic drug testing. Clin Chim Acta. 2014;436:224-236.10.1016/j.cca.2014.06.00224925169]Search in Google Scholar
[19. Beig A, Dahan A. Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic study. Biomed Chromatogr. 2014;28:934-938.10.1002/bmc.309524327551]Open DOISearch in Google Scholar
[20. Ates Z, Oezden T, Oezilhan S, Toptan S. Simultaneous determination of carbamazepine and its active metabolite carbamazepine-10,11-epoxide in human plasma by UPLC. Chromatographia. 2007;66:S123-S127.10.1365/s10337-007-0299-2]Open DOISearch in Google Scholar
[21. Nunes LAS, Mussavira S, Bindhu OS. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review. Biochem Med (Zagreb). 2015;25:177-192.10.11613/BM.2015.018447010726110030]Search in Google Scholar